Lung Cancer

Innovent:phase 3 Study On Advanced Lung Cancer Meets Predefined Primary Endpoint    Nasdaq

Smoking is associated with pneumonia development in lung cancer patients    MD Linx

Global Lung Marker Industry Forecast to 2025 - Market Breakup by EGFR, EML4-ALK, KRAS, and BRAF Marker Types    PRNewswire

Anaplastic Lymphoma Kinase Positive, Advanced Non-Small Cell Lung Cancer - 2020 Pipeline Landscape Overview - ResearchAndMarkets.com    Odessa American

Uptake in Lung Cancer Screening May Depend on Modalities Provided    Cancer Network

Mobile Lung CT coach to visit Cleveland    Cleveland Daily Banner

COVID-19 Patients With Cancer in New York City Have a High Death Rate    Cancer Health Treatment News

The clinical impact of COVID-19 and concurrent lung cancer    MD Linx

Clinton Woman With Stage 4 Lung Cancer Gets Birthday Surprise    NBC4 Washington

Sanofi, Regeneron take aim at Keytruda with Libtayo's first lung cancer win    FiercePharma

Regeneron, Sanofi immunotherapy extends survival in previously untreated lung cancer    BioPharma Dive

Regeneron and Sanofi drug extends survival in type of lung cancer    STAT

TERAVOLT: High Death Rate in Lung Cancer Patients With COVID-19    Medscape

Sanofi, Regeneron take aim at Keytruda with Libtayo's first lung cancer win    FiercePharma

Weekly Webinar Series Part 6: Managing Lung Cancer Patients Through the COVID-19 Pandemic    OncLive

Can Plasma Tumor Mutational Burden Measures Inform Lung Cancer Therapy Selection?    Cancer Therapy Advisor

FDA grants breakthrough therapy designation to mobocertinib for lung cancer subset    Healio

Regeneron and Sanofi drug extends survival in type of lung cancer    STAT

TERAVOLT: High Death Rate in Lung Cancer Patients With COVID-19    Medscape

Can Plasma Tumor Mutational Burden Measures Inform Lung Cancer Therapy Selection?    Cancer Therapy Advisor

Sanofi, Regeneron take aim at Keytruda with Libtayo's first lung cancer win    FiercePharma

Regeneron and Sanofi drug extends survival in type of lung cancer    STAT

Capmatinib shows efficacy in lung cancer subset, including patients with brain metastases    Healio

Lafayette man dying of lung cancer surprised with antique car parade    wlfi.com

ctDNA Identifies Adjuvant MRD Positivity, Relapse in Lung Cancer    www.oncnursingnews.com/

Immunotherapy and Brain Metastatic Lung Cancer    OncLive

Targeted Drugs Suggested by Molecular Tumor Board Shrunk Tumors in Two-Thirds of Lung Cancer Patients    Precision Oncology News

Interim Results from Phase Ib/II CLASSICAL-Lung Study Show Promise in NSCLC    Cancer Network

Sanofi, Regeneron take aim at Keytruda with Libtayo's first lung cancer win    FiercePharma

Lung cancer symptoms: The sign in your weight that could signal the deadly disease    Express

Cemiplimab NSCLC Trial Stopped Early After Demonstrating Survival Benefit    Pulmonology Advisor

Regeneron and Sanofi drug extends survival in type of lung cancer    STAT

Custom cell therapy shrinks lung tumors in advanced cancer cases    STAT

Lung Cancer vs. Metastatic Kidney Cancer: What's the Difference? | US News    U.S. News & World Report

Cemiplimab NSCLC Trial Stopped Early After Demonstrating Survival Benefit    Pulmonology Advisor

Pulmonary artery coil embolisation prevented tumour progression in a patient with advanced squamous cell lung carcinoma.    Physician's Weekly

Illinois US Navy Veterans Lung Cancer Advocate Offers a Navy Veteran or Person in Illinois with Lung Cancer and Who Had Heavy Asbestos Exposure to Call for Direct Access to the Lawyers at KVO-Take Compensation Seriously    MENAFN.COM

Can Plasma Tumor Mutational Burden Measures Inform Lung Cancer Therapy Selection?    Cancer Therapy Advisor

Custom cell therapy shrinks lung tumors in advanced cancer cases    STAT

Custom cell therapy shrinks lung tumors in advanced cancer cases    STAT

Spectrum Encouraged by Poziotinib Activity in Lung Cancer Subset, Despite Failing Primary Endpoint    Precision Oncology News

Interim Results from Phase Ib/II CLASSICAL-Lung Study Show Promise in NSCLC    Cancer Network

FDA grants breakthrough therapy designation to mobocertinib for lung cancer subset    Healio

Weekly Webinar Series Part 6: Managing Lung Cancer Patients Through the COVID-19 Pandemic    OncLive

Spectrum Encouraged by Poziotinib Activity in Lung Cancer Subset, Despite Failing Primary Endpoint    Precision Oncology News

Interim Results from Phase Ib/II CLASSICAL-Lung Study Show Promise in NSCLC    Cancer Network

FDA grants breakthrough therapy designation to mobocertinib for lung cancer subset    Healio